Skip to content

GASPS Study: General Anaesthesia vs Spinal anaesthesia: Patient outcomes and Success in Outpatient primary total knee and hip Arthroplasty

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520127-89-00
Enrollment
600
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total knee and hip arthroplasties

Brief summary

Successful same-day discharge, defined as: • The patient is discharged from the hospital on the same day as the surgery and, • the patient is not readmitted within 48 hours of discharge.

Detailed description

Time from start of anaesthesia to start of surgery (Phase II)., Time from start of surgery to discharge from the postoperative recovery unit (Phase II)., Time from start of surgery to fulfilment of indicators for end phase III (intermediate recovery) as outlined in the protocol (table 4)., Time from start of surgery to discharge from hospital (Phase III)., Time from start of surgery to first successful mobilisation, assessed by the ability to walk with tolerable pain and ascend/descend stairs if applicable., Use of analgesics (opioids converted to Oral morphine equivalents (OME))., Patient-reported quality of recovery using the Swedish Version of Quality of Recovery - 15 (QoR-15) from postoperative day (POD) 1 to POD 35., Pain levels measured using the Numeric Rating Scale (NRS) during the recovery period (postoperative until discharge to ward), Knee injury and Osteoarthritis Outcome Score (KOOS) at baseline, 4 weeks, 6 months 12 months., Hip disability and Osteoarthritis Outcome Score (HOOS), at baseline, 4 weeks, 6 months 12 months., Use of analgesics (opioids converted to Oral morphine equivalents (OME)). Daily postoperative day 1-14, weekly day 15-35, Incidence, severity and frequency of adverse events (AEs) and serious adverse events (SAEs), until postoperative day 3., Incidence and frequency of predefined adverse outcomes. (Table 1), until postoperative day 3., Units of blood transfusion, until discharge from hospital, Key themes from patient-reported experiences of anaesthesia and postoperative care, gathered through semi-structured interviews conducted 14–60 days post-surgery., Incremental cost-effectiveness ratios (ICERs) comparing costs and quality-adjusted life years (QALYs) gained between GA and SA.

Interventions

DRUGREMIFENTANIL
DRUGPROPOFOL
DRUGBUPIVACAINE
DRUGSUFENTANIL
DRUGFENTANYL

Sponsors

Region Oerebro Laen
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Successful same-day discharge, defined as: • The patient is discharged from the hospital on the same day as the surgery and, • the patient is not readmitted within 48 hours of discharge.

Secondary

MeasureTime frame
Time from start of anaesthesia to start of surgery (Phase II)., Time from start of surgery to discharge from the postoperative recovery unit (Phase II)., Time from start of surgery to fulfilment of indicators for end phase III (intermediate recovery) as outlined in the protocol (table 4)., Time from start of surgery to discharge from hospital (Phase III)., Time from start of surgery to first successful mobilisation, assessed by the ability to walk with tolerable pain and ascend/descend stairs if applicable., Use of analgesics (opioids converted to Oral morphine equivalents (OME))., Patient-reported quality of recovery using the Swedish Version of Quality of Recovery - 15 (QoR-15) from postoperative day (POD) 1 to POD 35., Pain levels measured using the Numeric Rating Scale (NRS) during the recovery period (postoperative until discharge to ward), Knee injury and Osteoarthritis Outcome Score (KOOS) at baseline, 4 weeks, 6 months 12 months., Hip disability and Osteoarthritis Outcome Score

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 1, 2026